Oligonucleotide Pool Market Research Report: Information by Type (DNA and RNA), Application (Research, Diagnostics & Therapeutics and other), End User (Commercial Research, Pure Academic Research and other) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2030

Oligonucleotide Pool Market Overview

The Oligonucleotide Pool Market is estimated to grow at a CAGR of 9.50%. As a result, the market value will further register up to USD 2.7 Billion by the end of the forecast period 2022-2030. The oligonucleotide sequencing is basically short nucleic acid polymers that are used for hybridizing RNA and DNA sequencing. The oligonucleotide drugs are manufactured in laboratories with the process called solid-phase chemical synthesis.  It is used for artificial gene synthesis, library construction and polymerase, and chain reaction.

Several drivers and market developments such as the high demand for oligonucleotide sequencing are expected to enhance the market growth. North America will hold the largest share in the Oligonucleotide Pool Market. Also, the market is divided into various segments such as type, application, and end-user. The investments by the large pharmaceutical companies and the growing demand for better healthcare facilities and treatment will enhance the market growth.

COVID-19 Analysis

The COVID-19 disease had a significant impact on the market. The lockdown for several months across the world causes huge financial strain. Due to this, many businesses had put shut down their manufacturing units. However, with the ease of lockdown restriction, several companies have come forward for collaboration and technological development in the Oligonucleotide Pool Market. Thus, the COVID-19 had a mixture of both positive and negative impacts on the market.

Global Oligonucleotide Pool Market Size, by End User, 2017 (USD Million)   Source: MRFR Analysis

Market Dynamics

Market Drivers

The major market drivers that are projected to boost the market growth are the huge investments by the pharmaceutical companies for the development of oligonucleotide therapeutics. Along with that, the growing demand for point-of-care testing products will boost the market growth in the forthcoming years.

Restraints

There are some restraints such as the shift in the supply chains for saving costs, and the changing focus of customers will hamper the market growth. Along with that, the high costs related to drug manufacturing and other developments will also restrict the market growth.

Opportunities

Various opportunities are anticipated to boost the Oligonucleotide Pool Market. The major investments by the major pharmaceutical companies for the development and research for oligonucleotide therapeutics will open new opportunities for market growth. Also, new acquisitions and mergers by the key players are helping the market to grow.

Challenges

The low presence of skilled laborers is the major challenge for the growth of the Oligonucleotide Pool Market. Also, the disruption caused by the COVID-19 disease has led to a huge financial burden upon small-scale as well as large-scale companies. However, the market will regain its growth in the upcoming years.

Cumulative Analysis

The Compound Annual Growth Rate (CAGR) of the Oligonucleotide Pool Market is anticipated to reach up to9.50%. According to MRFR analysis, the market value will touch up to USD 2.7 Billion by the end of the forecast period 2022-2030. Hence, the market will have positive growth in the upcoming years with significant demand for antisense oligonucleotide therapy.

Value Chain Analysis

The value chain of the market is evaluated to grow to strengthen with gradual and significant growth. Various drivers, opportunities, such as the high demand for oligonucleotide therapy will increase in the forecast period. Despite the several restraints, the market will flourish with the effective growth in the value chain of the market.

Asia-Pacific Oligonucleotide Pool Market Share, by Country, 2017 (%)  

Source: MRFR Analysis

Market Segmentations

The Oligonucleotide Pool Market segments are divided into end-user, application, and type. On the basis of type, the Oligonucleotide Pool Market is divided into RNA and DNA.

On the basis of application, the market is divided into therapeutics, and diagnostics, research, and others.

On the basis of end-user is segmented into pure academic research, commercial research, and others.

Regional Analysis

Regionally, the Oligonucleotide Pool Market is segmented into North America, Asia-Pacific, Europe, and the Middle East, and Africa. The MRFR analysis suggests that the North American region is evaluated to have the largest growth. It is mainly due to the presence of several manufacturers in the big-scale and small-scale industries in the countries such as the US and Canada. Also, the availability of several healthcare facilities such as diagnostic centers, state-of-the-art laboratories with technological advancements is promoting growth in this region.

Secondly, the European region holds the second position in the Oligonucleotide Pool Market. The rising development by the key players in genomics is fuelling market growth in the future. Also, supportive programs for drug administration for the approval of oligonucleotide therapeutics are a major reason for the growth.

Asia-Pacific region is anticipated to record the fastest growth in the forecast period. The rising developments for the research and developments in major countries such as India, Japan, China, etc. will further increase the value of the Oligonucleotide Pool Market. Along with that, the Middle East and African region will also have a gradual growth with the improvement in the healthcare facilities.

Competitive Landscape

The key players help to promote the growth of the Oligonucleotide Pool Market. They do mergers, product launches, collaborations, joint ventures, acquisitions, etc. These strategies help the key players to expand their business portfolio. These are some notable key players in the Oligonucleotide Pool Market.

• CustomArray Inc. (US)


• Sigma-Aldrich Co. LLC (US)


• Integrated DNA Technologies Inc. (US)


• Twist Bioscience (US)


• Creative Biogene (US)


• Agilent Technologies (US)


• TriLink BioTechnologies Inc. (US)


• Arbon Biosciences (US)


• Illumina (US)


• Eurofins Genomics (Germany)


• G.C. Biosearch Technologies (UK)

Recent Developments

• Twist Bioscience in April 2019, announced the agreement of antibody optimization with a company called Pandion Therapeutics.


• IDT in the year 2017 announced the launch of a service called RxnReady Oligo. This service will help the researchers to order several oligos for ready-to-use purposes easily.


• In 2019, IDT announced its partnership with a company called ChosenMed. It is a Chinese firm that is expected to strengthen the company to become a leading company.


• IDT announced the acquisition of an Australian company called GeneWorks.

Report Overview

The report overview of the Oligonucleotide Pool Market is as follows.

• Market Overview


• COVID-19 Analysis


• Dynamics of the Market


• Value Chain Analysis


• Market Segmentation


• Regional Analysis


• Competitive Analysis


• Recent Development

Report Score and Segmentation

• Study Period- 2022-2030


• Base Year-2021


• Forecast Period- 2022-2030


• Historical Period-2020

The report score of the Oligonucleotide Pool Market is to give information about the different market dynamics such as opportunities, market value, challenges, etc. during the forecast period 2022-2030. The information provided in this report is collected from secondary and primary sources.

Segmentation

• By Type


• RNA


• DNA

• By End User


• Pure Academic Research


• Commercial Research


• Others

• By Application


• Therapeutics and Diagnostics


• Research

• By Region


• North America


• Asia-Pacific


• Europe


• Latin America


• The Middle East and Africa